Theravance Biopharma, Inc.
TBPH
$16.48
-$0.04-0.24%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 25.15% | -4.34% | -2.69% | 158.92% | 48.11% |
| Total Receivables | -83.69% | 423.01% | -16.66% | 42.77% | -77.57% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -2.38% | 12.06% | 21.16% | 37.35% | -5.17% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -0.20% | 17.98% | -3.17% | 143.77% | -6.71% |
|
|
|||||
| Total Current Assets | -0.20% | 17.98% | -3.17% | 143.77% | -6.71% |
| Net Property, Plant & Equipment | -5.70% | -4.54% | -4.31% | -3.84% | -3.67% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.64% | -1.19% | -2.18% | -83.25% | 0.98% |
| Total Assets | -2.73% | 16.88% | -2.48% | 24.00% | -2.99% |
|
|
|||||
| Total Accounts Payable | -57.17% | 16.04% | 32.12% | -30.44% | 7.40% |
| Total Accrued Expenses | -24.95% | -3.48% | 31.50% | 23.58% | -6.36% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -1.76% | 0.28% | 0.17% | 0.82% | 0.89% |
| Total Finance Division Other Current Liabilities | 0.00% | 29.77% | -84.74% | 356.11% | 0.00% |
| Total Other Current Liabilities | 0.00% | 29.77% | -84.74% | 356.11% | 0.00% |
| Total Current Liabilities | -17.04% | 2.39% | -31.53% | 73.43% | -1.82% |
|
|
|||||
| Total Current Liabilities | -17.04% | 2.39% | -31.53% | 73.43% | -1.82% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -6.32% | -5.71% | -5.29% | -4.79% | -4.50% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.18% | 6.35% | 0.63% | 2.06% | 1.23% |
| Total Liabilities | -3.77% | 3.32% | -9.15% | 13.28% | -0.57% |
|
|
|||||
| Common Stock & APIC | -0.09% | 0.26% | 0.36% | 0.35% | 0.35% |
| Retained Earnings | -0.57% | 6.63% | 0.39% | 5.60% | -1.41% |
| Treasury Stock & Other | -201.64% | 90.63% | 420.00% | -- | -- |
| Total Common Equity | -2.07% | 27.52% | 3.48% | 35.46% | -5.45% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -2.07% | 27.52% | 3.48% | 35.46% | -5.45% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -2.07% | 27.52% | 3.48% | 35.46% | -5.45% |
|
|
|||||